What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?

The first-quarter 2024 reporting cycle of the Medical sector is about to pick up pace this week. The sector mainly comprises pharma/biotech and medical device companies.The earnings season for the drug and biotech sector kicked off last week when bellwether Johnson & Johnson reported mixed first-quarter results as it beat estimates for earnings but missed the same for sales.Yesterday, Swiss pharma giant Novartis AG reported better-than-expected first-quarter financial results, as its earnings and sales both ...